{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T07:35:16Z","timestamp":1785569716238,"version":"3.56.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cll.2026.02.007","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:07:08Z","timestamp":1778818028000},"page":"279-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Best Practices in Thrombophilia Testing"],"prefix":"10.1016","volume":"46","author":[{"given":"Ryan","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian A.","family":"Rollins-Raval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 Suppl","key":"10.1016\/j.cll.2026.02.007_bib1","doi-asserted-by":"crossref","first-page":"S495","DOI":"10.1016\/j.amepre.2009.12.017","article-title":"Venous thromboembolism: a public health concern","volume":"38","author":"Beckman","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.cll.2026.02.007_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2015.11.033","article-title":"The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs","volume":"137","author":"Grosse","year":"2016","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.cll.2026.02.007_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11239-015-1197-3","article-title":"Thrombophilia: clinical-practical aspects","volume":"39","author":"Moll","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.cll.2026.02.007_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11239-015-1316-1","article-title":"Guidance for the evaluation and treatment of hereditary and acquired thrombophilia","volume":"41","author":"Stevens","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"10.1016\/j.cll.2026.02.007_bib5","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1055\/s-0040-1714334","article-title":"Clinical utilization and cost of thrombophilia testing in patients with venous thromboembolism","volume":"4","author":"Gaddh","year":"2020","journal-title":"TH Open"},{"issue":"9","key":"10.1016\/j.cll.2026.02.007_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257687","article-title":"Evaluation of thrombophilia testing in the inpatient setting: a single institution retrospective review","volume":"16","author":"Siu","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.cll.2026.02.007_bib7","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.032","article-title":"An audit of thrombophilia testing in patients with ischemic stroke or transient ischemic attack: the futility of testing","volume":"27","author":"Gavva","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"25","key":"10.1016\/j.cll.2026.02.007_bib8","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/bloodadvances.2017009514","article-title":"A clinical audit of thrombophilia testing in pediatric patients with acute thromboembolic events: impact on management","volume":"1","author":"Gavva","year":"2017","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.cll.2026.02.007_bib9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.12788\/jhm.2804","article-title":"Patterns and appropriateness of thrombophilia testing in an academic medical center","volume":"12","author":"Cox","year":"2017","journal-title":"J Hosp Med"},{"issue":"23","key":"10.1016\/j.cll.2026.02.007_bib10","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMc1713797","article-title":"Thrombophilia testing and venous thrombosis","volume":"377","author":"Goodwin","year":"2017","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.cll.2026.02.007_bib11","first-page":"2298","article-title":"Thrombophilia testing and venous thrombosis","volume":"377","author":"Connors","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cll.2026.02.007_bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1515\/cclm-2018-1041","article-title":"Danger of false negative (exclusion) or false positive (diagnosis) for \u2019congenital thrombophilia\u2019 in the age of anticoagulants","volume":"57","author":"Favaloro","year":"2019","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"10.1016\/j.cll.2026.02.007_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155326","article-title":"Analysis of thrombophilia test ordering practices at an academic center: a proposal for appropriate testing to reduce harm and cost","volume":"11","author":"Shen","year":"2016","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.cll.2026.02.007_bib14","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.cll.2026.02.007_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjh.18239","article-title":"Thrombophilia testing: a British Society for Haematology guideline","volume":"198","author":"Arachchillage","year":"2022","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.cll.2026.02.007_bib16","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1542\/neo.15-5-e169","article-title":"Neonatal antiphospholipid syndrome","volume":"15","author":"Magalh\u00e3es","year":"2014","journal-title":"NeoReviews"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2026.02.007_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/ijlh.12665","article-title":"Review of D-dimer testing: good, bad, and ugly","volume":"39","author":"Linkins","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"22","key":"10.1016\/j.cll.2026.02.007_bib19","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/bloodadvances.2018024828","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism","volume":"2","author":"Lim","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.cll.2026.02.007_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.70079","article-title":"Facts and misfacts on D-dimer testing. consensus guidance from the Italian Society on Thrombosis and Hemostasis (SISET)","volume":"101","author":"Tripodi","year":"2026","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cll.2026.02.007_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-0716-3175-1_3","article-title":"Automation in the thrombosis and hemostasis laboratory","volume":"2663","author":"Salazar","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1016\/j.cll.2026.02.007_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0033-1364206","article-title":"Technological advances in the hemostasis laboratory","volume":"40","author":"Lippi","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cll.2026.02.007_bib23","unstructured":"CLSI. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays. 6th Ed. CLSI Guideline H21. Clinical and Laboratory Standards Institute; 2024."},{"issue":"Suppl 1","key":"10.1016\/j.cll.2026.02.007_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12288-014-0438-5","article-title":"Discrepancy in optical & mechanical method in coagulation tests in a turbid sample","volume":"30","author":"Aggarwal","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"3","key":"10.1016\/j.cll.2026.02.007_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/ijlh.13814","article-title":"Performance testing of four automated coagulation analyzers in a university hospital setting with focus on global coagulation assays","volume":"44","author":"Scherer-Buri\u0107","year":"2022","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"10.1016\/j.cll.2026.02.007_bib26","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/CIRCULATIONAHA.104.478222","article-title":"Coagulation assays","volume":"112","author":"Bates","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cll.2026.02.007_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.14648","article-title":"Recommendations for clinical laboratory testing for antithrombin deficiency; communication from the SSC of the ISTH","volume":"18","author":"Van Cott","year":"2020","journal-title":"J Thromb Haemostasis"},{"issue":"2","key":"10.1016\/j.cll.2026.02.007_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jth.14667","article-title":"Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH","volume":"18","author":"Cooper","year":"2020","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.cll.2026.02.007_bib29","series-title":"StatPearls. Treasure island (FL)","article-title":"Laboratory evaluation of coagulopathies","author":"Danilatou","year":"2024"},{"issue":"1","key":"10.1016\/j.cll.2026.02.007_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ejh.13339","article-title":"Clinical utility and impact of the use of the Chromogenic vs one-stage factor activity assays in haemophilia A and B","volume":"104","author":"Marlar","year":"2020","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.cll.2026.02.007_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MBC.0000000000000806","article-title":"Comparison of clot-based and chromogenic assay for the determination of protein c activity","volume":"30","author":"Roshan","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"10.1016\/j.cll.2026.02.007_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/ajcp\/87.1.94","article-title":"Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads","volume":"87","author":"Greenberg","year":"1987","journal-title":"Am J Clin Pathol"},{"issue":"16","key":"10.1016\/j.cll.2026.02.007_bib33","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1007\/s00216-024-05207-x","article-title":"Advances in D-dimer testing: progress in harmonization of clinical assays and innovative detection methods","volume":"416","author":"Zhao","year":"2024","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"10.1016\/j.cll.2026.02.007_bib34","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/ajh.25393","article-title":"Automated assays for von Willebrand factor activity","volume":"94","author":"Higgins","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cll.2026.02.007_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-0716-3175-1_14","article-title":"Testing for Factor V Leiden (FVL) and prothrombin G20210A genetic variants","volume":"2663","author":"Paji\u010d","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cll.2026.02.007_bib36","first-page":"1","article-title":"Outcomes of genetic testing in adults with a history of venous thromboembolism","volume":"180","author":"Segal","year":"2009","journal-title":"Evid Rep Technol Assess"},{"issue":"8","key":"10.1016\/j.cll.2026.02.007_bib37","doi-asserted-by":"crossref","first-page":"101466","DOI":"10.1016\/j.gim.2025.101466","article-title":"Venous thromboembolism laboratory testing (factor V Leiden and factor II c.\u221797G>A), 2025 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"27","author":"Kang","year":"2025","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.cll.2026.02.007_bib38","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlb\u00e4ck","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.cll.2026.02.007_bib39","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/jth.14532","article-title":"Subcommittee on plasma coagulation inhibitors. Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH","volume":"17","author":"Moore","year":"2019","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.cll.2026.02.007_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-2007-996019","article-title":"Laboratory diagnosis of hereditary thrombophilia","volume":"24","author":"Michiels","year":"1998","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"10.1016\/j.cll.2026.02.007_bib41","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1055\/s-0043-1770773","article-title":"Laboratory diagnosis of activated protein C resistance and factor V leiden","volume":"50","author":"Bahraini","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.cll.2026.02.007_bib42","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/ijlh.14447","article-title":"Activated protein C resistance testing: an update from Australasia\/Asia-Pacific","volume":"47","author":"Favaloro","year":"2025","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"10.1016\/j.cll.2026.02.007_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181faa0f2","article-title":"Factor V Leiden thrombophilia","volume":"13","author":"Kujovich","year":"2011","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.cll.2026.02.007_bib44","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/bjh.12506","article-title":"A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation","volume":"163","author":"Pr\u00fcller","year":"2013","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.cll.2026.02.007_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.21641","article-title":"All that glitters is gold?","volume":"85","author":"Van Cott","year":"2010","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.cll.2026.02.007_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ng578","article-title":"Increased efficiency of mRNA 3\u2019 end formation: a new genetic mechanism contributing to hereditary thrombophilia","volume":"28","author":"Gehring","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.cll.2026.02.007_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2018.07.008","article-title":"The genetics of antithrombin","volume":"169","author":"Corral","year":"2018","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.cll.2026.02.007_bib48","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","article-title":"Inherited antithrombin deficiency: a review","volume":"14","author":"Patnaik","year":"2008","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.cll.2026.02.007_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/CIRCULATIONAHA.113.003756","article-title":"Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study","volume":"129","author":"Di Minno","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cll.2026.02.007_bib50","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1538-7836.2012.04858.x","article-title":"Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism","volume":"10","author":"Bucciarelli","year":"2012","journal-title":"J Thromb Haemostasis"},{"issue":"6","key":"10.1016\/j.cll.2026.02.007_bib51","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1365-2516.2008.01838.x","article-title":"Protein C deficiency","volume":"14","author":"Goldenberg","year":"2008","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.cll.2026.02.007_bib52","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/jth.15732","article-title":"Diagnosis and management of severe congenital protein C deficiency (SCPCD): communication from the SSC of the ISTH","volume":"20","author":"Minford","year":"2022","journal-title":"J Thromb Haemostasis"},{"issue":"16","key":"10.1016\/j.cll.2026.02.007_bib53","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/jama.2025.0155","article-title":"Population-scale studies of protein S abnormalities and thrombosis","volume":"333","author":"Chaudhry","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cll.2026.02.007_bib54","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ajh.21992","article-title":"Protein S abnormalities: a diagnostic nightmare","volume":"86","author":"Marlar","year":"2011","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.cll.2026.02.007_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jth.15109","article-title":"Recommendations for clinical laboratory testing for protein S deficiency: communication from the SSC committee plasma coagulation inhibitors of the ISTH","volume":"19","author":"Marlar","year":"2021","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.cll.2026.02.007_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/jth.15108","article-title":"Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH","volume":"19","author":"Brinkman","year":"2021","journal-title":"J Thromb Haemostasis"},{"issue":"6","key":"10.1016\/j.cll.2026.02.007_bib57","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.jtha.2024.12.041","article-title":"Multigene panel for thrombophilia testing in venous thromboembolism","volume":"23","author":"Verstraete","year":"2025","journal-title":"J Thromb Haemostasis"},{"issue":"3","key":"10.1016\/j.cll.2026.02.007_bib58","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jtha.2024.12.006","article-title":"Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening","volume":"23","author":"Suchon","year":"2025","journal-title":"J Thromb Haemostasis"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T18:04:14Z","timestamp":1783620254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271226000077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0272271226000077"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2026.02.007","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Best Practices in Thrombophilia Testing","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2026.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}